AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

LABCORP HOLDINGS INC. Director's Dealing 2016

Oct 4, 2016

30237_dirs_2016-10-04_c75e0602-8cb5-4c61-9a40-b01394be894b.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: LABORATORY CORP OF AMERICA HOLDINGS (LH)
CIK: 0000920148
Period of Report: 2016-10-01

Reporting Person: Ratliff John D (CEO, Covance Drug Development)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	40	Direct